tiprankstipranks
Immuneering (IMRX)
NASDAQ:IMRX
US Market
Holding IMRX?
Track your performance easily

Immuneering (IMRX) Income Statement

281 Followers

Immuneering Income Statement

Last quarter (Q3 2024), Immuneering's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Immuneering's net income was $-14.60M. See Immuneering’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 19.20K-$ 316.95K$ 2.08M$ 2.31M$ 1.92M
Cost of Revenue
--$ 158.12K$ 1.15M$ 1.28M$ 1.22M
Gross Profit
$ 19.20K-$ 158.83K$ 926.89K$ 1.03M$ 696.74K
Operating Expense
$ 61.82M$ 58.41M$ 51.90M$ 34.81M$ 18.11M$ 6.99M
Operating Income
$ -61.82M$ -58.41M$ -51.74M$ -33.89M$ -17.08M$ -6.29M
Net Non Operating Interest Income Expense
$ 2.93M$ 3.61M$ -1.01M$ 169.90K$ 42.66K$ -1.42M
Other Income Expense
$ -814.42K$ 1.33M$ 216.84K$ 176.07K--
Pretax Income
$ -58.07M$ -53.47M$ -50.51M$ -33.84M$ -17.04M$ -7.71M
Tax Provision
$ 699.53K$ 699.53K$ 541.07K$ -307.49K--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -58.07M$ -53.47M$ -50.51M$ -33.58M$ -17.04M$ -7.71M
Basic EPS
$ -1.96$ -1.88$ -1.91$ -2.46$ -1.99$ -0.90
Diluted EPS
$ -1.96$ -1.88$ -1.90$ -2.46$ -1.99$ -0.90
Basic Average Shares
$ 118.18M$ 28.42M$ 26.39M$ 13.61M$ 8.58M$ 8.58M
Diluted Average Shares
$ 118.18M$ 28.42M$ 26.39M$ 13.61M$ 8.58M$ 8.58M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----$ 112.00K-
Total Expenses
$ 61.82M$ 58.41M$ 52.06M$ 35.97M$ 19.39M$ 8.21M
Net Income From Continuing And Discontinued Operation
$ -58.07M$ -53.47M$ -50.51M$ -33.54M$ -17.04M$ -7.71M
Normalized Income
$ -54.47M$ -42.24M-$ -34.15M$ -17.04M$ -7.71M
Interest Expense
----$ 0.00$ 351.30K
EBIT
$ -59.29M$ -58.41M$ -51.75M$ -33.84M$ -17.08M$ -7.36M
EBITDA
$ -58.65M$ -58.06M$ -51.47M$ -33.68M$ -17.00M$ -7.34M
Currency in USD

Immuneering Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis